It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences
The growth and adoption of the internet and mobile technology have provided publishers and authors...
What do Healthcare Professionals Want from Medical Affairs Post COVID-19?
Here's an interesting read for medical affairs teams on how to cater to the digital...
A 4-Step Plan to Drive HCP Engagement
HCPs are a time-constrained and hard-to-engage audience. Learn how pharma can digitally engage HCPs better...
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...